Study: NCT02065336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: entecavir

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: entecavir

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chlorpheniramine
Description: In all cohorts, each participant received an 8 mg dose of oral chlorpheniramine 2 hours prior to each administration of ARC-520 Injection.